Acorda Therapeutics Q2 Profit Decreases - Quick Facts

(RTTNews) - Acorda Therapeutics, Inc. (ACOR) reported second-quarter net income of $3.9 million or $0.09 per share, including share-based compensation charges totaling $6.5 million. GAAP net income in the same quarter of 2012 was $4.5 million, or $0.11 per share, including share-based compensation charges totaling $5.6 million.

Non-GAAP net income for the quarter ended June 30, 2013 was $10.4 million, or $0.25 per share.

On average, ten analysts polled by Thomson Reuters expected the company to report profit per share of $0.09 for the quarter. Analysts' estimates typically exclude special items.

Total revenues increased to $87.05 million, from $75.66 million last year. Analysts expected revenue of $82.57 million for the quarter.